Evidence map›Paper›PMID 30359446›Full record

ArticlePloS one2018

ABO blood types and major outcomes in patients with acute hypoxaemic respiratory failure: A multicenter retrospective cohort study.

Emanuele Rezoagli, Stefano Gatti, Silvia Villa, Giulia Villa, Stefano Muttini, Fabio Rossi, Loredana Faraldi, Roberto Fumagalli, Giacomo Grasselli, Giuseppe Foti and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Histo-blood group A is a risk factor for severe COVID-19.Transfusion medicine (Oxford, England) · 2022
    Observational
  6. Observational
  7. Article
  8. Observational
  9. Article
  10. ABO blood types and sepsis mortality.Annals of intensive care · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Emanuele RezoagliSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Stefano GattiSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Silvia VillaSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Giulia VillaSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Stefano MuttiniDepartment of Emergency Medicine and Intensive Care, "Ospedale Civile" Vimercate, Vimercate, Monza Brianza, Italy.
Fabio RossiImmunotransfusional Unit, San Gerardo Hospital, Monza, Italy.
Loredana FaraldiDepartment of Anesthesia and Critical Care, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Roberto FumagalliSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Giacomo GrasselliDipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milan, Italy.
Giuseppe FotiSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Giacomo BellaniSchool of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.ORCID 0000-0002-3089-205X
Azienda Ospedaliera San Gerardo · ITUniversity of Milano-Bicocca · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITAzienda Ospedaliera di Desio e Vimercate · ITOllscoil na Gaillimhe – University of Galway · IEUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionABO blood type A was reported to correlate with an increased risk of acute respiratory distress syndrome (ARDS) in white patients with severe sepsis and major trauma compared with patients with other blood types. Information regarding ABO phenotypes and major outcomes in patients with ARDS is unavailable. The primary aim was to determine the relationship between ABO blood type A and intensive care unit (ICU) mortality in patients with acute hypoxemic respiratory failure (AHRF). The secondary aim was to describe the association between ABO blood type A and ICU length of stay (LOS) in this study population.

methodsIn a multicenter, retrospective cohort study, we collected the clinical records of patients admitted from January 2012 to December 2014 in five ICUs of Northern Italy. We included adult white patients admitted to the ICU who were diagnosed with AHRF requiring mechanical ventilation.

resultsThe electronic records of 1732 patients with AHRF were reviewed. The proportion of patients with ABO blood type A versus other blood types was 39.9% versus 60.1%. ICU mortality (25%) and ICU LOS (median [interquartile range], 5 [2-12] days) were not different when stratified by ABO blood type (ICU mortality, overall p value = 0.905; ICU LOS, overall p value = 0.609). SAPSII was a positive predictor of ICU mortality (odds ration [OR], 32.80; 95% confidence interval [CI], 18.80-57.24; p < 0.001) and ICU LOS (β coefficient, 0.55; 95% CI, 0.35-0.75; p < 0.001) at multivariate analyses, whereas ABO blood type did not predict ICU outcome when forced into the model.

conclusionABO blood type did not correlate with ICU mortality and ICU LOS in adult patients with AHRF who were mechanically ventilated.

Indexed as

ABO Blood-Group SystemFemaleHumansIntensive Care UnitsLength of StayLinear ModelsMaleMiddle AgedMultivariate AnalysisRespiratory Distress SyndromeRetrospective StudiesABO Blood-Group System

Identifiers

PMID30359446
PMCPMC6201964
OpenAlexW2898358979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.